| |
| |
|
| Insider
Information: |
Murphy Andrew J |
| Relationship: |
EVP Research |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
48,306 |
|
|
Indirect Shares
|
4,310 |
|
|
| Direct
Value |
$47,564,020 |
|
|
|
Indirect Value
|
$4,243,798 |
|
|
| Total
Shares |
52,616 |
|
|
| Total
Value |
$51,807,818 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Research |
2024-03-14 |
48,306 |
2024-03-14 |
4,310 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP ResearchOfficer |
• – – |
2019-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,212 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-07-13 |
4 |
AS |
$620.64 |
$5,028,022 |
D/D |
(8,000) |
41,951 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-07-14 |
4 |
AS |
$630.77 |
$1,507,677 |
D/D |
(2,380) |
41,951 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-07-14 |
4 |
AS |
$614.62 |
$2,451,277 |
D/D |
(3,929) |
44,331 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP ResearchOfficer |
• – – |
2019-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,326 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-10-22 |
4 |
OE |
$30.63 |
$199,926 |
D/D |
5,185 |
47,136 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-11-17 |
4 |
AS |
$536.68 |
$3,597,188 |
D/D |
(6,628) |
47,136 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-07-13 |
4 |
D |
$623.98 |
$4,175,050 |
D/D |
(6,691) |
48,260 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-12 |
4 |
D |
$856.71 |
$6,559,828 |
D/D |
(7,657) |
48,306 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2024-03-14 |
4 |
AS |
$951.92 |
$5,531,290 |
D/D |
(5,783) |
48,306 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-01-27 |
4 |
AS |
$336.78 |
$2,727,279 |
D/D |
(8,000) |
49,951 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-11-16 |
4 |
D |
$561.39 |
$3,990,360 |
D/D |
(7,108) |
53,764 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2024-03-13 |
4 |
D |
$971.82 |
$13,816,365 |
D/D |
(14,217) |
54,089 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-07-13 |
4 |
OE |
$30.63 |
$398,190 |
D/D |
13,000 |
54,951 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-08-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,645 |
55,705 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-11-16 |
4 |
AS |
$642.76 |
$4,638,263 |
D/D |
(7,167) |
55,705 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2023-12-11 |
4 |
D |
$844.09 |
$4,873,776 |
D/D |
(5,774) |
55,963 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-12-09 |
4 |
D |
$753.28 |
$370,614 |
D/D |
(492) |
56,618 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-11-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,360 |
57,110 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-11-15 |
4 |
AS |
$718.60 |
$2,707,467 |
D/D |
(3,720) |
57,110 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,214 |
57,350 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2019-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,625 |
57,951 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2021-12-11 |
4 |
D |
$664.34 |
$463,045 |
D/D |
(697) |
58,470 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-02-15 |
4 |
AS |
$622.09 |
$2,227,851 |
D/D |
(3,540) |
58,470 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Research |
• – – |
2022-05-17 |
4 |
AS |
$655.40 |
$2,351,411 |
D/D |
(3,543) |
58,470 |
0 |
% |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
